Support for Pharmacist-Provided HPV Vaccination: National Surveys of U.S. Physicians and Parents
- PMID: 29871883
- PMCID: PMC6092750
- DOI: 10.1158/1055-9965.EPI-18-0380
Support for Pharmacist-Provided HPV Vaccination: National Surveys of U.S. Physicians and Parents
Abstract
Background: State laws about pharmacists providing human papillomavirus (HPV) vaccines vary considerably, limiting many pharmacists' ability to provide this important cancer prevention service. We characterized physician and parent support for pharmacist-provided HPV vaccination for adolescents who are past due for vaccination.Methods: In 2014 to 2015, we conducted two national U.S. surveys of 776 primary care physicians (PCPs) and 1,504 parents of adolescents. Respondents indicated the extent to which they supported pharmacist-provided HPV vaccination for 13- to 17-year-olds who are past due. Respondents could endorse the provision unconditionally, or only if certain conditions were met, such as pharmacists receiving proper vaccination training. We used multivariable logistic regression to assess correlates of support.Results: Most physicians (79%) and parents (81%) endorsed pharmacist-provided HPV vaccination if pharmacists had received proper vaccination training, reported vaccine doses to adolescents' PCP, and referred adolescents to PCPs for other health services. Family medicine physicians were more likely than pediatricians to support trained pharmacists providing HPV vaccination [OR = 1.62; 95% confidence interval (CI) 1.17-2.22]. Support was also higher among physicians who practiced in Western states (OR = 2.11; 95% CI, 1.30-3.40). Parents' odds of endorsing trained pharmacists provision of HPV vaccine increased with higher overall satisfaction with their pharmacy's services (OR = 1.10; 95% CI, 1.02-1.19), belief in pharmacists' competence in vaccination practices (OR = 1.42; 95% CI, 1.18-1.70), and overall vaccine confidence (OR = 1.30; 95% CI, 1.15-1.48).Conclusions: To increase support for HPV vaccination services, pharmacists should raise awareness about their immunization training and standardize vaccination protocols that ensure coordination with primary care.Impact: Stakeholders' feedback and buy-in is important to help guide expansion of HPV vaccination in pharmacies. Cancer Epidemiol Biomarkers Prev; 27(8); 970-8. ©2018 AACR.
©2018 American Association for Cancer Research.
Conflict of interest statement
Figures
References
-
- Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States—2010-2014. Atlanta, GA: Centers for Disease Control and Prevention; 2017.
-
- Meites E, Kempe A, Markowitz L. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination—Updated Recommendations of the Advisory Committee on Immunization Practices. American Journal of Transplantation. 2017;17(3):834–837. - PubMed
-
- Rimer B, Harper H, Witte O. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A Report to the President of the United States from the President’s Cancer Panel Bethesda, MD: National Cancer Institute. 2014
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
